First-line tyrosine kinase inhibitors in EGFR mutation-positive non-small-cell lung cancer: a network meta-analysis

Marscha S Holleman*, Harm van Tinteren, Harry Jm Groen, Maiwenn J Al, Carin A Uyl-de Groot

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

44 Citations (Scopus)
29 Downloads (Pure)

Fingerprint

Dive into the research topics of 'First-line tyrosine kinase inhibitors in EGFR mutation-positive non-small-cell lung cancer: a network meta-analysis'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science